Back to tickers

Iterum Therapeutics plc (ITRM)

Nasdaq · CIK 0001659323

Form Report Date Filing Date Description
8-K 2026-03-30 2026-03-31 8-K
8-K 2026-03-27 2026-03-27 8-K
8-K 2026-03-03 2026-03-03 8-K
8-K 2026-02-24 2026-03-02 8-K
8-K 2026-02-18 2026-02-18 8-K
8-K 2025-12-11 2025-12-12 8-K
10-Q 2025-09-30 2025-11-14 10-Q
8-K 2025-11-14 2025-11-14 8-K
8-K 2025-10-16 2025-10-16 8-K
8-K 2025-09-10 2025-09-10 8-K
8-K 2025-08-25 2025-08-28 8-K
8-K 2025-08-20 2025-08-20 8-K
10-Q 2025-06-30 2025-08-05 10-Q
8-K 2025-08-05 2025-08-05 8-K
8-K 2025-07-29 2025-08-04 8-K
8-K 2025-07-17 2025-07-18 8-K
8-K 2025-06-06 2025-06-11 8-K
8-K 2025-05-13 2025-05-19 8-K
10-Q 2025-03-31 2025-05-13 10-Q
8-K 2025-05-13 2025-05-13 8-K
8-K 2025-04-28 2025-04-30 8-K
8-K 2025-03-07 2025-03-10 8-K
8-K 2025-02-14 2025-02-14 8-K
10-K 2024-12-31 2025-02-07 10-K
8-K 2025-02-07 2025-02-07 8-K
8-K 2024-12-10 2024-12-11 8-K
8-K 2024-11-20 2024-11-21 8-K
10-Q 2024-09-30 2024-11-14 10-Q
8-K 2024-11-14 2024-11-14 8-K
8-K 2024-10-28 2024-11-01 8-K
8-K 2024-10-25 2024-10-25 8-K
8-K 2024-10-09 2024-10-15 8-K
8-K 2024-10-08 2024-10-08 8-K
8-K 2024-10-01 2024-10-04 8-K
10-Q 2024-06-30 2024-08-14 10-Q
8-K 2024-08-14 2024-08-14 8-K
8-K 2024-08-06 2024-08-06 8-K
8-K 2024-07-22 2024-07-22 8-K
8-K 2024-06-26 2024-06-26 8-K
8-K 2024-06-19 2024-06-21 8-K
8-K 2024-05-29 2024-05-31 8-K
10-Q 2024-03-31 2024-05-13 10-Q
8-K 2024-05-13 2024-05-13 8-K
8-K 2024-05-10 2024-05-10 8-K
8-K 2024-04-29 2024-04-29 8-K
8-K 2024-04-03 2024-04-05 8-K
8-K 2024-03-28 2024-03-29 8-K
10-K 2023-12-31 2024-03-28 10-K
8-K 2024-03-06 2024-03-06 8-K
8-K 2024-01-30 2024-01-30 8-K
8-K 2024-01-30 2024-01-30 8-K
8-K 2023-12-28 2023-12-29 8-K
8-K 2023-12-04 2023-12-04 8-K
10-Q 2023-09-30 2023-11-14 10-Q
8-K 2023-11-14 2023-11-14 8-K
8-K 2023-10-24 2023-10-24 8-K
8-K 2023-09-26 2023-10-02 8-K
10-Q 2023-06-30 2023-08-11 10-Q
8-K 2023-08-11 2023-08-11 8-K
8-K 2023-08-01 2023-08-01 8-K
10-Q 2023-03-31 2023-05-12 10-Q
8-K 2023-05-12 2023-05-12 8-K
8-K 2023-05-03 2023-05-04 8-K
10-K 2022-12-31 2023-03-16 10-K
8-K 2023-03-16 2023-03-16 8-K
8-K 2023-02-17 2023-02-17 8-K
8-K 2022-12-15 2022-12-15 8-K
10-Q 2022-09-30 2022-11-10 10-Q
8-K 2022-11-10 2022-11-10 8-K
8-K 2022-10-20 2022-10-20 8-K
8-K 2022-09-19 2022-09-19 8-K
8-K 2022-08-17 2022-08-19 8-K
10-Q 2022-06-30 2022-08-12 10-Q
8-K 2022-08-12 2022-08-12 8-K
8-K 2022-07-28 2022-07-28 8-K
8-K 2022-07-11 2022-07-11 8-K
8-K 2022-07-07 2022-07-08 8-K
8-K 2022-06-15 2022-06-16 8-K
10-Q 2022-03-31 2022-05-13 10-Q
8-K 2022-05-13 2022-05-13 8-K
10-K 2021-12-31 2022-03-28 10-K
8-K 2022-03-28 2022-03-28 8-K_EARNINGS RELEASE_MARCH2022
10-Q 2021-09-30 2021-11-12 10-Q
8-K 2021-11-12 2021-11-12 8-K_EARNING RELEASE Q3 2021
8-K 2021-09-07 2021-09-10 8-K_BID PRICE
10-Q 2021-06-30 2021-08-13 10-Q
8-K 2021-08-13 2021-08-13 8-K_Q2 EARNINGS RELEASE
8-K 2021-07-26 2021-07-26 8-K_CRL
8-K 2021-07-01 2021-07-02 8-K_REGULATORY UPDATE
8-K 2021-06-23 2021-06-23 8-K_AGM
8-K 2021-06-08 2021-06-14 8-K
8-K 2021-05-27 2021-05-27 8-K_FDA MEETING UPDATE
10-Q 2021-03-31 2021-05-14 10-Q
8-K 2021-05-14 2021-05-14 8-K_Q1 2021 EARNINGS RELEASE
8-K 2021-04-08 2021-04-09 8-K
8-K 2021-03-11 2021-03-16 8-K
10-K 2020-12-31 2021-03-12 10-K
8-K 2021-03-12 2021-03-12 8-K_10K EARNINGS RELEASE
8-K 2021-02-17 2021-02-22 8-K_M DUNNE CONSULTANCY
8-K 2021-02-09 2021-02-11 8-K
8-K 2021-02-09 2021-02-10 8-K
8-K 2021-02-03 2021-02-05 8-K
8-K 2021-02-01 2021-02-01 8-K_BUSINESS UPDATE
8-K 2021-01-22 2021-01-28 8-K_EGM RESULTS
8-K 2020-12-18 2020-12-23 8-K
8-K 2020-12-18 2020-12-21 8-K
10-Q 2020-09-30 2020-11-16 10-Q
8-K 2020-11-16 2020-11-16 8-K_EARNINGS RELEASE Q3_2020
8-K 2020-10-22 2020-10-27 8-K
8-K 2020-09-30 2020-09-30 8-K_PRE NDA MEETING
8-K 2020-09-24 2020-09-25 8-K_BID PRICE_AFFILIATE MKT V
8-K 2020-08-31 2020-09-01 8-K
8-K 2020-08-11 2020-08-11 8-K_ROLAUNCH
10-Q 2020-06-30 2020-08-06 10-Q
8-K 2020-08-06 2020-08-06 8-K_EARNINGS RELEASE Q2
8-K 2020-07-15 2020-07-17 8-K_MVLS JULY
8-K 2020-07-13 2020-07-13 8-K_RIGHTS OFFERING
8-K 2020-06-30 2020-07-01 8-K
8-K 2020-06-29 2020-06-29 FORM 8-K
8-K 2020-06-10 2020-06-15 8-K - AGM RESOLUTIONS
8-K 2020-06-03 2020-06-04 8-K
8-K 2020-06-01 2020-06-03 8-K
8-K 2020-05-13 2020-05-15 8-K_MVLS
10-Q 2020-03-31 2020-05-14 10-Q FOR THE PERIOD ENDING 31 MARCH 2020
8-K 2020-05-14 2020-05-14 8-K
10-K 2019-12-31 2020-03-12 10-K
8-K 2020-03-12 2020-03-12 8-K_EARNINGS RELEASE Q1 2020
8-K 2020-03-04 2020-03-06 8-K
8-K 2020-02-12 2020-02-14 8-K
8-K 2020-01-16 2020-01-17 8-K
10-Q 2019-09-30 2019-11-12 10-Q
8-K 2019-11-12 2019-11-12 8-K
10-Q 2019-06-30 2019-08-14 10-Q
8-K 2019-08-14 2019-08-14 8-K_Q2 EARNINGS RELEASE 2019
8-K 2019-06-13 2019-06-17 8-K
10-Q 2019-03-31 2019-05-14 10-Q
8-K 2019-05-14 2019-05-14 8-K
10-K 2018-12-31 2019-03-25 10-K
8-K 2019-03-25 2019-03-25 8-K
10-Q 2018-09-30 2018-11-14 10-Q
8-K 2018-11-14 2018-11-14 8-K
8-K 2018-10-19 2018-10-19 FORM 8-K
10-Q 2018-06-30 2018-08-14 10-Q
8-K 2018-08-14 2018-08-14 8-K
8-K 2018-05-30 2018-05-30 FORM 8-K